Detalhe da pesquisa
1.
Safety and Efficacy of Mitapivat in Pyruvate Kinase Deficiency.
N Engl J Med
; 381(10): 933-944, 2019 09 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31483964
2.
Effect of itraconazole, food, and ethnic origin on the pharmacokinetics of ivosidenib in healthy subjects.
Eur J Clin Pharmacol
; 75(8): 1099-1108, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31011758
3.
The Pyruvate Kinase Deficiency Global Longitudinal (Peak) Registry: rationale and study design.
BMJ Open
; 13(3): e063605, 2023 03 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36958777
4.
Ivosidenib in Isocitrate Dehydrogenase 1-Mutated Advanced Glioma.
J Clin Oncol
; 38(29): 3398-3406, 2020 10 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32530764
5.
Molecular mechanisms mediating relapse following ivosidenib monotherapy in IDH1-mutant relapsed or refractory AML.
Blood Adv
; 4(9): 1894-1905, 2020 05 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32380538
6.
Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer.
N Engl J Med
; 349(2): 146-53, 2003 Jul 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-12853587
7.
Randomized comparison of low molecular weight heparin and coumarin derivatives on the survival of patients with cancer and venous thromboembolism.
J Clin Oncol
; 23(10): 2123-9, 2005 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15699480
8.
Phase 1b study of safety, tolerability and efficacy of R1507, a monoclonal antibody to IGF-1R in combination with multiple standard oncology regimens in patients with advanced solid malignancies.
Cancer Chemother Pharmacol
; 73(3): 467-73, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24390424
9.
ATLAS: randomized, double-blind, placebo-controlled, phase IIIB trial comparing bevacizumab therapy with or without erlotinib, after completion of chemotherapy, with bevacizumab for first-line treatment of advanced non-small-cell lung cancer.
J Clin Oncol
; 31(31): 3926-34, 2013 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24101054